Delaet Ingrid — SEC Form 4 filings
SEC reporting owner CIK 1965808. 24 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2024-02-02 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 33 legs across 21 filings — 55,476 shares, $8,606,101 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 78.
- Largest priced transaction: sale of 8,433 shares @ $178.72 ($1,507,135) in NEUROCRINE BIOSCIENCES INC, filed 2026-07-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Regulatory Officer | 24 | — | 33 legs · 55,476 sh · $8,606,101 | 78 |
Form 4 filings — Delaet Ingrid
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 4,483 @ $0 · Tax withholding (F): 2,419 @ $156.22 | EDGAR |
| 2026-07-13 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 4,367 @ $106.02 · Sale (S): 4,367 @ $181.02 · Option exercise (M): 4,367 (derivative) @ $0 | EDGAR |
| 2026-07-09 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 3,401 @ $103.52 · Sale (S): 3,401 @ $178.57 · Option exercise (M): 2,737 @ $103.52 · Sale (S): 2,737 @ $178.54 · Option exercise (M): 8,433 @ $103.52 · Sale (S): 8,433 @ $178.72 · +3 more | EDGAR |
| 2026-06-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,261 @ $79.02 · Sale (S): 2,261 @ $156.71 · Option exercise (M): 2,261 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,600 @ $0 · Tax withholding (F): 881 @ $123.10 · Option exercise (M): 1,401 @ $0 · Tax withholding (F): 756 @ $124.12 · Option exercise (M): 1,359 @ $0 · Tax withholding (F): 734 @ $124.12 · +7 more | EDGAR |
| 2026-02-03 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 801 @ $0 · Tax withholding (F): 475 @ $136.06 · Option exercise (M): 801 (derivative) @ $0 | EDGAR |
| 2025-07-11 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 457 @ $79.02 · Sale (S): 457 @ $135 · Option exercise (M): 457 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,358 @ $0 · Sale (S): 716 @ $116.69 · Option exercise (M): 1,401 @ $0 · Sale (S): 755 @ $116.72 · Grant/award (A): 34,153 (derivative) @ $0 · Grant/award (A): 6,401 (derivative) @ $0 · +2 more | EDGAR |
| 2025-02-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 801 @ $0 · Sale (S): 422 @ $153.05 · Option exercise (M): 1,179 @ $0 · Sale (S): 623 @ $149.29 · Option exercise (M): 801 (derivative) @ $0 · Option exercise (M): 1,179 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 272 @ $79.02 · Sale (S): 272 @ $138.10 · Option exercise (M): 272 (derivative) @ $0 | EDGAR |
| 2024-12-19 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,091 @ $79.02 · Sale (S): 1,091 @ $135 · Option exercise (M): 1,091 (derivative) @ $0 | EDGAR |
| 2024-08-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 3,043 @ $103.52 · Sale (S): 3,043 @ $150.13 · Sale (S): 4,100 @ $150.08 · Option exercise (M): 3,043 (derivative) @ $0 | EDGAR |
| 2024-08-08 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 273 @ $79.02 · Sale (S): 273 @ $147.70 · Option exercise (M): 273 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 400 @ $103.52 · Sale (S): 400 @ $150.10 · Option exercise (M): 1,557 @ $103.52 · Sale (S): 1,557 @ $150 · Sale (S): 900 @ $150.04 · Option exercise (M): 400 (derivative) @ $0 · +1 more | EDGAR |
| 2024-07-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 272 @ $79.02 · Sale (S): 272 @ $138.11 · Option exercise (M): 272 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 273 @ $79.02 · Sale (S): 273 @ $136.55 · Option exercise (M): 273 (derivative) @ $0 | EDGAR |
| 2024-05-08 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 273 @ $79.02 · Sale (S): 273 @ $140.55 · Option exercise (M): 273 (derivative) @ $79.02 | EDGAR |
| 2024-04-03 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 272 @ $79.02 · Sale (S): 272 @ $137.30 · Option exercise (M): 272 (derivative) @ $79.02 | EDGAR |
| 2024-03-25 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 5,000 @ $103.52 · Sale (S): 5,000 @ $145.06 · Option exercise (M): 5,000 (derivative) @ $103.52 | EDGAR |
| 2024-03-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 3,000 @ $106.02 · Sale (S): 3,000 @ $140.14 · Option exercise (M): 3,000 (derivative) @ $106.02 | EDGAR |
| 2024-03-12 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,800 @ $106.02 · Sale (S): 1,800 @ $140.03 · Option exercise (M): 200 @ $106.02 · Sale (S): 200 @ $140 · Option exercise (M): 1,800 (derivative) @ $106.02 · Option exercise (M): 200 (derivative) @ $106.02 | EDGAR |
| 2024-02-29 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,500 @ $79.02 · Sale (S): 2,500 @ $135.64 · Option exercise (M): 2,500 @ $79.02 · Sale (S): 2,500 @ $134.62 · Option exercise (M): 1,544 @ $79.02 · Sale (S): 1,544 @ $136 · +6 more | EDGAR |
| 2024-02-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 716 @ $133.03 · Grant/award (A): 28,161 (derivative) @ $0 · Grant/award (A): 5,604 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 422 @ $141.94 · Sale (S): 623 @ $139.77 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1965808 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →